Abstract
The effects of cannabinoids in mitochondria after acute oxidative stress insult are not fully established. We investigated the ability of CP55,940 and JWH-015 to scavenge reactive oxygen species and their effect on mitochondria permeability transition (MPT) in either a mitochondria-free superoxide anion generation system, intact rat brain mitochondria or in sub-mitochondrial particles (SMP) treated with paraquat (PQ). Oxygen consumption, mitochondrial membrane potential (Δψm) and MPT were determined as parameters of mitochondrial function. It is found that both cannabinoids effectively attenuate mitochondrial damage against PQ-induced oxidative stress by scavenging anion superoxide radical (O2 ∙−) and hydrogen peroxide (H2O2), maintaining Δψm and by avoiding Ca2+-induced mitochondrial swelling. Understanding the mechanistic action of cannabinoids on mitochondria might provide new insights into more effective therapeutic approaches for oxidative stress related disorders.
Similar content being viewed by others
References
Elsohly MA, Slade D (2005) Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci 78:539–548
Smita K, Sushil-Kumar V, Premendran JS (2007) Anandamide: an update. Fundam Clin Pharmacol 21:1–8
Padgett LW (2005) Recent developments in cannabinoid ligands. Life Sci 77:1767–1798
Szabo B (2008) Pharmacology of cannabinoid receptors. Biotrend Rev 2:1–13
Sagredo O, García-Arencibia M, de Lago E, Finetti S, Decio A, Fernández-Ruiz J (2007) Cannabinoids and neuroprotection in basal ganglia disorders. Mol Neurobiol 36:82–91
Martínez-Orgado J, Fernández-López D, Lizasoain I, Romero J (2007) The seek of neuroprotection: introducing cannabinoids. Recent Patents CNS Drug Discov 2:131–139
de Lago E, Fernández-Ruiz J (2007) Cannabinoids and neuroprotection in motor-related disorders. CNS Neurol Disord Drug Targets 6:377–387
Hampson AJ, Grimaldi M, Axelrod J, Wink D (1998) Cannabidiol and (−)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci USA 95:8268–8273
Chen Y, Buck J (2000) Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism. J Pharmacol Exp Ther 293:807–812
Marsicano G, Moosmann B, Hermann H, Lutz B, Behl C (2002) Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J Neurochem 80:448–456
Lastres-Becker I, Fernandez-Ruiz J (2006) An overview of Parkinson’s disease and the cannabinoid system and possible benefits of cannabinoid-based treatments. Curr Med Chem 13:3705–3718
Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, Greenberg DA (1999) Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 19:2987–2995
Kim SH, Won SJ, Mao XO, Jin K, Greenberg DA (2005) Involvement of protein kinase A in cannabinoid receptor-mediated protection from oxidative neuronal injury. J Pharmacol Exp Ther 313:88–94
Velez-Pardo C, Jimenez-Del-Rio M (2006) Avoidance of Aβ[25–35]/(H2O2)-induced apoptosis in lymphocytes by the cannabinoid agonists CP55,940 and JWH-015 via receptor-independent and PI3 K-dependent mechanisms: role of NF-κB and p53. Med Chem 2:471–479
Garcia-Arencibia M, Gonzalez S, de Lago E, Ramos JA, Mechoulam R, Fernandez-Ruiz J (2007) Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: importance of antioxidant and cannabinoid receptor-independent properties. Brain Res 1134:162–170
Jimenez-Del-Rio M, Daza-Restrepo A, Velez-Pardo C (2008) The cannabinoid CP55,940 prolongs survival and improves locomotor activity in Drosophila melanogaster against paraquat: implications in Parkinson’s disease. Neurosci Res 61:404–411
Jimenez-Del-Rio M, Velez-Pardo C (2008) Paraquat induces apoptosis in human lymphocytes: Protective and rescue effects of glucose, cannabinoids and Insulin-like growth factor-1. Growth Factors 26:49–60
Halestrap AP (2009) What is the mitochondrial permeability transition pore? J Mol Cell Cardiology 46:821–831
Lemasters JJ, Theruvath TP, Zhong Z, Nieminen AL (2009) Mitochondrial calcium and the permeability transition in cell death. Biochim Biophys Acta 1787:1395–1401
Uttara B, Singh AV, Zamboni P, Mahajan RT (2009) Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 7:65–74
Lores-Arnaiz S, Coronel MF, Boveris A (1999) Nitric oxide, superoxide and hydrogen peroxide production in brain mitochondria after haloperidol treatment. Nitric Oxide: Biol Chem 3:235–243
Boveris A (1984) Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Meth Enzymol 105:429–435
Boveris A, Oshino N, Chance B (1972) The cellular production of hydrogen peroxide. Biochem J 128:617–627
Chance B, Williams GR (1956) The respiratory chain and oxidative phosphorylation. Adv Enzymol 17:65–134
Estabrook RW (1967) Mitochondrial respiratory control and the polarographic measurement of ADP:O ratios. Meth Enzymol 10:41–47
Mattiasson G, Friberg H, Hansson M, Elmér E, Wieloch T (2003) Flow cytometric analysis of mitochondria from CA1 and CA3 regions of rat hippocampus reveals differences in permeability transition pore activation. J Neurochem 87:532–544
Bustamante J, Di Libero E, Fernandez-Cobo M, Monti N, Cadenas E, Boveris A (2004) Kinetic analysis of thapsigargin–induced thymocyte apoptosis. Free Rad Biol Med 37:1490–1498
Misra HP, Fridovich I (1972) The role of superoxide anion in the autoxidatrion of epinephrineand a simple assay for superoxide dismutase. J Biol Med 10:3170–3175
Gogvadze V, Robertson JD, Zhivotovsky B, Orrenius S (2002) Cytochrome c release occurs via Ca2+ dependent and Ca2+ independent mechanisms that are regulated by Bax. Proc Natl Acad Sci USA 99:1259–1263
Bustamante J, Nutt L, Orrenius S, Gogvadze V (2005) Arsenic stimulates release of cytochrome c from isolated mitochondria via induction of mitochondrial permeability transition. Toxicol Appl Pharmacol 207(2 Suppl):110–116
Czerniczyniec A, Bustamante J, Lores-Arnaiz S (2006) Modulation of brain mitochondrial function by deprenyl. Neurochem Int 48:235–241
Bernardi P, Scorrano L, Colonia R, Petronilli V, Di Lisa F (1999) Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur J Biochem 264:687–701
Hunter DR, Haworth RA (1979) The Ca++-induced membrane transition in mitochondria. I. The protective mechanisms. Arch Biochem Biophys 195:453–459
Cafiso DS (1994) Alamethicin a peptide model for voltage gaiting and protein-membrane interactions. Ann Rev Biophys Biomol Struct 23:141–165
Hansson MJ, Persson T, Friberg H, Keep MF, Rees A, Wieloch T, Elmer E (2003) Powerful cyclosporine inhibition of calcium-induced permeability transition in brain mitochondria. Brain Res 960:99–111
Costa B, Parolaro D, Colleoni M (1996) Chronic cannabinoid, CP-55, 940, administration alters biotransformation in the rat. Eur J Pharmacol 313:17–24
Cochemé HM, Murphy MP (2008) Complex I is the major site of mitochondrial superoxide production by paraquat. J Biol Chem 283:1786–1798
Loschen G, Azzi A, Richter C, Flohé L (1974) Superoxide radicals as precursors of mitochondrial hydrogen peroxide. FEBS Lett 42:68–72
Forman HJ, Kennedy JA (1974) Role of superoxide radical in mitochondrial dehydrogenase reactions. Biochem Biophys Res Commun 60:1044–1050
Prabhakar NR, Kumar GK (2004) Oxidative stress in the systemic and cellular responses to intermittent hypoxia. Biol Chem 385:217–221
Gray JP, Heck DE, Mishin PJS, Hong JY, Thiruchelvam M, Cory-Slechta DA, Laskin DL, Laskin JD (2007) Paraquat increases cyanide-insensitive respiration in murine lung epithelial cells by activating an NAD(P)H:paraquat oxidoreductase. J Biol Chem 282:7939–7949
Sarafian TA, Kouyoumjian S, Khoshaghideh F, Tashkin DP, Roth MD (2003) Delta 9-tetrahydrocannabinol disrupts mitochondrial function and cell energetics. Am J Physiol Lung Cell Mol Physiol 284:L298–L306
Athanasiou A, Clarke AB, Turner AE, Kumaran NM, Vakilpour S, Smith PA, Bagiokou D, Bradshaw TD, Westwell AD, Fang L, Lobo DN, Constantinescu CS, Calabrese V, Loesch A, Alexander SP, Clothier RH, Kendall DA, Bates TE (2007) Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. Biochem Biophys Res Commun 364:131–137
Ryan D, Drysdale AJ, Lafourcade C, Pertwee RG, Platt B (2009) Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels. J Neurosci 29:2053–2063
Costantini P, Petronilli V, Colonna R, Bernardi P (1995) On the effects of paraquat on isolated mitochondria. Evidence that paraquat causes opening of the cyclosporin A-sensitive permeability transition pore synergistically with nitric oxide. Toxicology 99((1–2)):77–88
Acknowledgments
This study was supported by grants from Colciencias (#1115-343-19119), “Proyecto Enfermedades Neurodegenerativas- University of Antioquia” (#8780), Programa de Sostenibilidad 2008/2009 to CV-P and MJ-Del-Rio, and by grants from University of Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) and Agencia Nacional de Promoción de Científica y Tecnológica (ANPCYT), Argentina.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Velez-Pardo, C., Jimenez-Del-Rio, M., Lores-Arnaiz, S. et al. Protective Effects of the Synthetic Cannabinoids CP55,940 and JWH-015 on Rat Brain Mitochondria upon Paraquat Exposure. Neurochem Res 35, 1323–1332 (2010). https://doi.org/10.1007/s11064-010-0188-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-010-0188-1